55
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Southern Saskatchewan Ticagrelor Registry experience

, , , , , , , , & show all
Pages 1427-1435 | Published online: 16 Oct 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Dimitrios Alexopoulos, Ioanna Xanthopoulou, Angelos Perperis, John Goudevenos, Michalis Hamilos, George Sitafidis, Ioannis Kanakakis, Manolis Vavouranakis, George Giannopoulos, Nikolaos Barampoutis, Spyridon Deftereos & John Lekakis. (2017) Dyspnea in patients treated with P2Y12 receptor antagonists: insights from the GReek AntiPlatElet (GRAPE) registry. Platelets 28:7, pages 691-697.
Read now
Aldona Kubica, Karolina Obońska, Tomasz Fabiszak & Jacek Kubica. (2016) Adherence to antiplatelet treatment with P2Y12 receptor inhibitors. Is there anything we can do to improve it? A systematic review of randomized trials. Current Medical Research and Opinion 32:8, pages 1441-1451.
Read now

Articles from other publishers (6)

Dominick J. Angiolillo, Giuseppe Patti, Kam Tim Chan, Yaling Han, Wei-Chun Huang, Alexey Yakovlev, Dara Paek, Michael del Aguila, Shalini Girotra & Dirk Sibbing. (2019) De-escalation from ticagrelor to clopidogrel in acute coronary syndrome patients: a systematic review and meta-analysis. Journal of Thrombosis and Thrombolysis 48:1, pages 1-10.
Crossref
Sameer Arora, Kamal Shemisa, Muthiah Vaduganathan, Arman Qamar, Ankur Gupta, Sushil K. Garg, Dharam J. Kumbhani, Helen Mayo, Houman Khalili, Ambarish Pandey & Sandeep R. Das. (2019) Premature Ticagrelor Discontinuation in Secondary Prevention of Atherosclerotic CVD. Journal of the American College of Cardiology 73:19, pages 2454-2464.
Crossref
Manuel Almendro-Delia, Ángel García-Alcántara, M. Victoria de la Torre-Prados, Antonio Reina-Toral, José Andrés Arboleda-Sánchez, Michel Butrón-Calderón, Alberto García-Guerrero, Rafael de la Chica-Ruiz Ruano, Rafael Hidalgo-Urbano & Juan C. García-Rubira. (2017) Seguridad y eficacia clínica con prasugrel y ticagrelor en síndrome coronario agudo. Resultados de un registro multicéntrico en el mundo real. Revista Española de Cardiología 70:11, pages 952-959.
Crossref
Manuel Almendro-Delia, Ángel García-Alcántara, M. Victoria de la Torre-Prados, Antonio Reina-Toral, José Andrés Arboleda-Sánchez, Michel Butrón-Calderón, Alberto García-Guerrero, Rafael de la Chica-Ruiz Ruano, Rafael Hidalgo-Urbano & Juan C. García-Rubira. (2017) Safety and Efficacy of Prasugrel and Ticagrelor in Acute Coronary Syndrome. Results of a “Real World” Multicenter Registry. Revista Española de Cardiología (English Edition) 70:11, pages 952-959.
Crossref
I-Chih Chen, Cheng-Han Lee, Yi-Heng Li & Ting-Hsing Chao. (2017) Reply. Journal of the Chinese Medical Association 80:3, pages 185-186.
Crossref
D. Alexopoulos, I. Xanthopoulou, S. Deftereos, M. Hamilos, G. Sitafidis, I. Kanakakis, I. Pentara, M. Vavouranakis, P. Davlouros, G. Hahalis & J. Goudevenos. (2016) Contemporary antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: 1‐year outcomes from the GReek AntiPlatElet (GRAPE) Registry. Journal of Thrombosis and Haemostasis 14:6, pages 1146-1154.
Crossref